Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DGPR1008 for intraoperative imaging in prostate cancer
NCT07024030Phase 2Completed
- Sponsor
- Qingdao Niu Haitao Medical Technology
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of DGPR1008 in prostate cancer (PCa), sponsored by Qingdao Niu Haitao Medical Technology. Started Oct 2024; status: completed.
02
Drugs
DGPR1008
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07024030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07024030.